. 2012 Jun;53(6):1117–1125. doi: 10.1194/jlr.M021485

TABLE 1.

Body weight gain, food intake, and relative adipose depot masses corrected for body weight of rats treated with rapamycin (Rapa) and/or rosiglitazone (RSG) for 15 days

	Control	Rapa	RSG	Rapa + RSG
Body weight gain (g)	98.3 ± 2.7^a	12.6 ± 2.3^b	111.2 ± 2.7^c	9.61 ± 3.0^b
Food intake (g)	214 ± 9.6^a	179 ± 10.1^b	242 ± 12.0^a	167 ± 8.6^b
Food efficiency^d (%)	65.3 ± 1.2^a	11.6 ± 2.3^b	71.6 ± 2.1^a	13.6 ± 2.6^b
Retroperitoneal fat (%)	0.87 ± 0.05^a	0.53 ± 0.04^b	0.84 ± 0.05^a	0.79 ± 0.04^a
Inguinal fat (%)	1.06 ± 0.08^a	0.90 ± 0.04^a	1.58 ± 0.06^b	1.26 ± 0.04^c
Brown fat (%)	0.09 ± 0.01^a	0.08 ± 0.01^a	0.33 ± 0.02^b	0.18 ± 0.02^c
Adiponectin (μg/ml)	2.44 ± 0.25^a	3.17 ± 0.28^a	9.38 ± 1.01^b	6.66 ± 1.45^c

Data are average ± SE, n = 12–20 rats. All groups had the same average body weight (230 g) at the onset of treatments.

^a,b,c

Means not sharing a common superscript are significantly different from each other, P < 0.05.

Calculated as grams of body weight gain per 100 g of food ingested.